ARCHIVES

In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends

This article is from The Cancer Letter archive.

Vol. 02 No. 16 | April 16, 1976

Download PDF Visit The Full Archive

Related Articles

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Funding opportunities listed.

July 23, 2004

Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.

November 30, 2001

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

NCI Plans a Catalog Of Research Tools

April 30, 1999

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982